Atlas Trials

Duration of Benefit for OnabotulinumtoxinA in Treatment of Chronic Migraine

Clinical trial NCT02037425 · COMPLETED

Trial details

NCT number
NCT02037425
Sponsor
Cady, Roger, M.D.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Migraine
Start date
2014-04-01
Primary completion
2015-09-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.